MANAGING MIGRAINE WITH INDIVIDUALIZED HOMOEOPATHIC MEDICINES: INSIGHTS FROM A TWO-CASE SERIES
DOI:
https://doi.org/10.69980/ajpr.v28i5.827Keywords:
Migraine, Headache, Homoeopathy, Individualization, MIDAS, Homoeopathic MedicinesAbstract
Migraine is a debilitating neurological condition. World Health Organization and Global burden of diseases study 2021 reports that it affects approximately 1 billion individuals globally and ranks third as cause of disability-adjusted life years among neurological disorders. Migraine is characterised by recurrent episodes of unilateral headache which may or may not be accompanied by sensory and autonomic symptoms. Conventional treatment options have higher possibility of medication overuse and side effects. Homoeopathy offers a holistic, individualized approach which addresses physical, mental and emotional well-being of the patient. This case series presents clinical course and outcomes of two patients presenting with chronic migraine with associated symptoms managed with individualized homoeopathic medicines. Patients demonstrated substantial improvement in headache frequency, intensity and associated symptoms and marked reduction in disability which was assessed by the Migraine Disability Assessment Scale (MIDAS). This illustrates the potential of constitutional homoeopathic prescribing in migraine management and highlights the value of systematic case documentation using validated outcome measures such as MIDAS.
References
1. International Headache Society. The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia. 2018;38(1):1-211.
2. World Health Organization. Migraine and other headache disorders [Internet]. Geneva: WHO; 24 Oct 2025 [cited 2025-11-14]. Available from: https://www.who.int/news-room/fact-sheets/detail/headache-disorders
3. Global Burden of Disease Study 2021. Migraine prevalence and disability-adjusted life years (DALYs). Published 2024.
4. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20-28.
5. van Haselen RA. Homeopathic clinical case reports: Development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complementary Therapies in Medicine. 2016;25:78-85
6. Goadsby PJ. Migraine and other primary headache disorders. In: Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s Principles of Internal Medicine. 21st ed. New York: McGraw Hill; 2022. p. 3357.
7. Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018;17(2):174-182.
8. American Migraine Foundation. Diagnosis and treatment of migraine [Internet]. American Migraine Foundation website; 2023 [accessed on 2025 Nov 8]. Available from: https://americanmigrainefoundation.org/migraine-diagnosis-treatment/
9. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994;117(1):199-210. doi: 10.1093/brain/117.1.199.
10. Walker BR, Colledge NR, Ralston SH, Penman ID, editors. Davidson’s Principles and Practice of Medicine. 24th ed. Edinburgh: Elsevier; 2022. p. 1150.
11. Kumar P, Clark M. Migraine. In: Kumar P, Clark M, editors. Kumar & Clark’s Clinical Medicine. 10th ed. Edinburgh: Elsevier; 2021. p. 849.
12. Hahnemann S. Organon of Medicine. 5th ed. Translated by Dudgeon RE. New Delhi: B. Jain Publishers; 2000. ISBN No: 9788131903117
13. Hompath Software Pvt Ltd. Hompath Zomeo (homeopathic repertory software, version x.x) [computer software]. Mumbai, India: Hompath Software Pvt Ltd; 2016.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 American Journal of Psychiatric Rehabilitation

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License permitting all use, distribution, and reproduction in any medium, provided the work is properly cited.
